iBio, Inc. Common Stock
IBIO
XNAS
•
PHARMACEUTICAL PREPARATIONS
Market Cap
71M
Short interest (Jul 15)
10.8%
Net Short (Jul 27 ): -0.1%
Borrow Fee
3.22%
Available Shares
2M
Price Chart
Company Overview
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Company Info
Exchange:
NASDAQ
Industry:
PHARMACEUTICAL PREPARATIONS
CIK:
0001420720
Asset Type:
CS
Market Data
Market Cap:
$71,040,342
Employees:
20
Status:
Active
Short Interest
Current Borrow Fee
3.22%
Range: 2.20% -
3.22%
Available Shares
2M
Range: 1.4M -
1.5M
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.